Teva Pharmaceutical Industries (TEVA) Selling, General & Administrative (2009 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn | 317.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 1.13 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 304.42 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | 148.72 Mn |
| 5 | Bausch Health Companies | 2.37 Bn | 528.25 Mn | 2.10 Bn | 907.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -43.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 91.66 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 18.24 Mn |
| 9 | Fennec Pharmaceuticals | 411.43 Mn | 370.18 Mn | 17.15 Mn | 4.64 Mn |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 317.00 Mn |
| Mar 31, 2026 | 304.00 Mn |
| Dec 31, 2025 | 367.00 Mn |
| Sep 30, 2025 | 317.00 Mn |
| Jun 30, 2025 | 305.00 Mn |
| Mar 31, 2025 | 297.00 Mn |
| Dec 31, 2024 | 302.00 Mn |
| Sep 30, 2024 | 298.00 Mn |
| Jun 30, 2024 | 283.00 Mn |
| Mar 31, 2024 | 278.00 Mn |
| Dec 31, 2023 | 292.00 Mn |
| Sep 30, 2023 | 268.00 Mn |
| Jun 30, 2023 | 307.00 Mn |
| Mar 31, 2023 | 296.00 Mn |
| Dec 31, 2022 | 288.00 Mn |
| Sep 30, 2022 | 283.00 Mn |
| Jun 30, 2022 | 313.00 Mn |
| Mar 31, 2022 | 296.00 Mn |
| Dec 31, 2021 | 277.00 Mn |
| Sep 30, 2021 | 291.00 Mn |